SCHEMBL25192052

SCHEMBL25192052

CN(C)C(=O)C#CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31271521 0.73 LMNA (0.34)
SCHEMBL16784554 0.72 NPSR1 (0.56)
SCHEMBL13028437 0.69
SCHEMBL4159602 0.67 NPSR1 (0.46)
SCHEMBL8950863 0.67
SCHEMBL8950836 0.67
SCHEMBL2880722 0.65
SCHEMBL24682898 0.63 NPSR1 (0.39)
SCHEMBL30301007 0.63
SCHEMBL25189500 0.62 NPSR1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353854-A1 FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF MENIN BIOMEA FUSION INC (US) 2025-11-20 US disclosed
US-20250066386-A1 INHIBITORS OF KRAS BIOMEA FUSION, INC. 2025-02-27 US disclosed
WO-2023235618-A1 FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF MENIN BIOMEA FUSION, INC. (US) 2023-12-07 WO disclosed
WO-2023086341-A1 INHIBITORS OF KRAS BIOMEA FUSION, INC. (US) 2023-05-19 WO disclosed